Yale Scientists Identify Proteins Spreading Parkinson's

Yale scientists announced this week the identification of two neuron surface proteins that appear to facilitate the spread of alpha-synuclein, the toxic protein implicated in Parkinson's disease. These proteins, identified through extensive research, act as conduits, enabling the misfolded alpha-synuclein to move from one neuron to another, a process critical to the disease's progression. The findings were published in the journal Nature Neuroscience.

In laboratory experiments involving mice models of Parkinson's disease, the research team demonstrated that blocking these specific neuron surface proteins significantly reduced the spread of alpha-synuclein aggregates. This intervention led to a dramatic slowing of disease progression in the animal subjects. The discovery offers a promising new avenue for developing therapies aimed at halting or reversing the neurodegenerative effects of Parkinson's.

Dr. Jaime Granda, a lead author on the study, stated that this breakthrough provides a concrete target for drug development. By inhibiting the function of these identified proteins, future treatments could potentially prevent the widespread neuronal damage characteristic of Parkinson's. The research team is now focused on developing compounds that can effectively and safely block these proteins in humans, aiming to translate these findings into clinical applications.